Cascade screening and treatment of children with familial hypercholesterolemia in Turkey

Engin Kose1, Melis Kose1, Sureyya Ipek Ozturk2

  • 1Department of Pediatric Metabolism and Nutrition, Katip Celebi University Faculty of Medicine, Izmir, Turkey.

Insights

Screening children for familial hypercholesterolemia (FH) is vital for early detection and treatment. Lipid-lowering treatments, including statins, are effective, but challenges in treatment initiation persist.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Familial hypercholesterolemia (FH) is a common genetic disorder leading to premature coronary artery disease.
  • Early detection and management of FH are crucial for preventing cardiovascular events.
  • A national lipid screening program for school-age children was established in Turkey in 2016.

Purpose of the Study:

  • To evaluate the effectiveness of a lipid screening program for identifying children with FH.
  • To assess the efficacy of lipid-lowering treatments, including diet and statins, in pediatric FH patients.
  • To identify challenges associated with initiating and adhering to FH treatments in children.

Main Methods:

  • Retrospective evaluation of pediatric patients diagnosed with FH.
  • Assessment of lipid profiles following dietary interventions and statin therapy.
  • Analysis of cascade screening results in families of diagnosed children.

Main Results:

  • Fifty-one children with FH (mean age 9.8 years) were included; all had heterozygous LDLR gene mutations.
  • Dietary intervention led to a 14.5% decrease in LDL-C levels.
  • Statin treatment reduced mean LDL-C from 204.1 mg/dL to 137.0 mg/dL, with 15.7% of parents refusing statin initiation.
  • Cascade screening identified FH in 13.7% of parents and led to new treatment for relatives.

Conclusions:

  • Pediatric FH screening is essential for early diagnosis in children and their families.
  • Diet and statins effectively lower LDL-C in children with FH.
  • Significant resistance to initiating statin therapy was observed, highlighting a key challenge in management.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
246
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
335
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.6K
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.7K